Correlation Between Eliem Therapeutics and Kineta
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Kineta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Kineta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Kineta Inc, you can compare the effects of market volatilities on Eliem Therapeutics and Kineta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Kineta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Kineta.
Diversification Opportunities for Eliem Therapeutics and Kineta
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eliem and Kineta is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Kineta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kineta Inc and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Kineta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kineta Inc has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Kineta go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Kineta
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.79 times more return on investment than Kineta. However, Eliem Therapeutics is 1.27 times less risky than Kineta. It trades about 0.03 of its potential returns per unit of risk. Kineta Inc is currently generating about -0.02 per unit of risk. If you would invest 321.00 in Eliem Therapeutics on August 26, 2024 and sell it today you would lose (21.00) from holding Eliem Therapeutics or give up 6.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.75% |
| Values | Daily Returns |
Eliem Therapeutics vs. Kineta Inc
Performance |
| Timeline |
| Eliem Therapeutics |
| Kineta Inc |
Eliem Therapeutics and Kineta Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Kineta
The main advantage of trading using opposite Eliem Therapeutics and Kineta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Kineta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kineta will offset losses from the drop in Kineta's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Kineta vs. Eliem Therapeutics | Kineta vs. HCW Biologics | Kineta vs. Scpharmaceuticals | Kineta vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |